Paclitaxel: new uses for an old drug

Area of Science:

• Oncology
• Pharmacology
• Cell Biology

Background:

• Paclitaxel (Taxol) is a vital chemotherapeutic agent widely used in cancer treatment.
• Its primary mechanism involves stabilizing microtubules, disrupting cell division, and inducing apoptosis.
• Recent findings indicate potential therapeutic applications beyond oncology.

Purpose of the Study:

• To review the established anticancer functions of paclitaxel.
• To explore the emerging evidence for paclitaxel's efficacy in non-cancerous diseases.
• To highlight the need for mechanistic understanding to guide future therapeutic development.

Main Methods:

• Literature review of paclitaxel's mechanisms of action in cancer.
• Survey of recent studies investigating low-dose paclitaxel in non-cancerous conditions.
• Analysis of potential therapeutic targets and pathways.

Main Results:

• Paclitaxel effectively inhibits cancer cell proliferation by interfering with microtubule dynamics.
• Low-dose paclitaxel demonstrates promise in treating skin disorders, fibrosis (renal and hepatic), inflammation, and promoting axon regeneration.
• It also shows potential in limb salvage and preventing coronary artery restenosis.

Conclusions:

• Paclitaxel's established role in oncology is well-defined.
• Emerging evidence supports a broader therapeutic scope for paclitaxel, particularly at low doses, in non-cancerous conditions.
• Further research is crucial to elucidate the specific mechanisms driving these novel effects and optimize targeted therapies.